PHASE II CLINICAL TESTING OF HEMOGLOBIN-BASED OXYGEN CARRIER-201 FOR USE IN THE TREATMENT OF TRAUMA

$3,506,503FY2008Department of the ArmyDOD

Biopure Corporation

Investigators